These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1849133)
21. Effect of thromboxane A2 synthetase inhibitor on immediate-type hypersensitivity reactions. Nakagawa T; Miyamoto T; Urata C; Mano K; Yukawa T; Makino S Int Arch Allergy Appl Immunol; 1987; 82(3-4):539-40. PubMed ID: 2437053 [TBL] [Abstract][Full Text] [Related]
22. A double-blind, placebo-controlled trial of the thromboxane synthetase blocker OKY-046 on bronchial hypersensitivity in bronchial asthma patients. Kunitoh H; Watanabe K; Nagatomo A; Okamoto H; Nakagawa T J Asthma; 1998; 35(4):355-60. PubMed ID: 9669829 [TBL] [Abstract][Full Text] [Related]
23. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). Tomoda H Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743 [TBL] [Abstract][Full Text] [Related]
24. [Effects of a specific thromboxane A2 synthetase inhibitor on lymphocyte and neutrophil functions in adult intractable asthmatics]. Kanehiro A; Takahashi K; Soda R; Takata M; Takeda K; Sugano H; Yamagata K; Katagi Y; Kimura I Arerugi; 1992 May; 41(5):584-94. PubMed ID: 1325764 [TBL] [Abstract][Full Text] [Related]
25. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans. Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531 [No Abstract] [Full Text] [Related]
26. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364 [TBL] [Abstract][Full Text] [Related]
27. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217 [TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of inhalation of a thromboxane synthetase inhibitor on bronchoconstriction induced by aerosolized leukotriene C4 and thromboxane A2 analogue in anesthetized guinea pigs. Fujimura M; Ogawa H; Saito M; Sakamoto S; Miyake Y; Matsuda T Allergy; 1991 Oct; 46(7):534-9. PubMed ID: 1796779 [TBL] [Abstract][Full Text] [Related]
29. [Arachidonic acid metabolites in exercise-induced asthma]. Hoshino M Arerugi; 1989 Dec; 38(12):1302-10. PubMed ID: 2634372 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness. Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552 [TBL] [Abstract][Full Text] [Related]
31. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels]. Baba H Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521 [TBL] [Abstract][Full Text] [Related]
32. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Isozaki H; Okajima K; Hara H; Kobayashi M Surg Today; 1994; 24(5):435-40. PubMed ID: 8054815 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of a selective thromboxane synthetase inhibitor, OKY-046, on acetaldehyde-induced bronchoconstriction in asthmatic patients. Myou S; Fujimura M; Nishi K; Ohka T; Masuda T Chest; 1994 Nov; 106(5):1414-8. PubMed ID: 7956393 [TBL] [Abstract][Full Text] [Related]
34. [Effect of OKY-046 on airway hyperresponsiveness induced by ozone in dogs]. Nambu F; Imai T; Adachi M; Takahashi T Nihon Yakurigaku Zasshi; 1990 May; 95(5):271-7. PubMed ID: 2354834 [TBL] [Abstract][Full Text] [Related]
35. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats. Iida T; Yokoi H; Kawarada Y Pancreas; 1998 Aug; 17(2):140-7. PubMed ID: 9700944 [TBL] [Abstract][Full Text] [Related]
36. Roles of thromboxane A2 and leukotriene B4 in radicular pain induced by herniated nucleus pulposus. Kawakami M; Matsumoto T; Tamaki T J Orthop Res; 2001 May; 19(3):472-7. PubMed ID: 11398862 [TBL] [Abstract][Full Text] [Related]
37. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs]. Takehana Y; Hamano S; Kikuchi S; Kusama H; Komatsu H; Okegawa T; Ikeda S Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):21-30. PubMed ID: 2303203 [TBL] [Abstract][Full Text] [Related]
38. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome. Niwa T; Maeda K; Shibata M; Yamada K Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971 [TBL] [Abstract][Full Text] [Related]
39. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats. Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452 [TBL] [Abstract][Full Text] [Related]
40. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046. Hatziantoniou C; Papanikolaou N Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]